The detailed information for PTAB case with proceeding number IPR2018-00421 filed by Catalent Pharma Solutions, Inc. against Patheon Softgels Inc. et al. on Jan 14, 2018. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number
IPR2018-00421
Filing Date
Jan 14, 2018
Petitioner
Catalent Pharma Solutions, Inc.
Respondent
Patheon Softgels Inc. et al.
Status
Institution Denied
Respondent Application Number
14977808
Respondent Tech Center
1600
Respondent Patent Number
9693978
Institution Decision Date
Aug 13, 2018

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.


Document NameFiling DateCategoryFiling Party

Alert me when new update on this case

Notice of Refund

Dec 17, 2018PAPERBOARD

Petitioner's Request for Refund of Post-Institution Fees Under 37 CFR 1.26

Oct 9, 2018PAPERPETITIONER

Trial Instituted Document

Aug 13, 2018PAPERBOARD

Khan Declaration

May 22, 2018EXHIBITPATENT OWNER

Ranucci 1994

May 22, 2018EXHIBITPATENT OWNER

WO9531194

May 22, 2018EXHIBITPATENT OWNER

Shah 1989

May 22, 2018EXHIBITPATENT OWNER

Crowley 2004

May 22, 2018EXHIBITPATENT OWNER

Patent Owner's Exhibit List

May 22, 2018PAPERPATENT OWNER

Khan CV

May 22, 2018EXHIBITPATENT OWNER

Serajuddin 1999

May 22, 2018EXHIBITPATENT OWNER

Patravale 2004

May 22, 2018EXHIBITPATENT OWNER

WO9531979

May 22, 2018EXHIBITPATENT OWNER

Serajuddin 1986

May 22, 2018EXHIBITPATENT OWNER

PDR - Naprosyn

May 22, 2018EXHIBITPATENT OWNER

PDR - Aleve

May 22, 2018EXHIBITPATENT OWNER

PDR - Naprelan

May 22, 2018EXHIBITPATENT OWNER

Merisko-Liversidge 2003

May 22, 2018EXHIBITPATENT OWNER

PDR - Anaprox

May 22, 2018EXHIBITPATENT OWNER

Naprosyn FDA approval 1976

May 22, 2018EXHIBITPATENT OWNER

Anaprox FDA approval 1980

May 22, 2018EXHIBITPATENT OWNER

Naprelan FDA approval 1996

May 22, 2018EXHIBITPATENT OWNER

ICH Guidelines

May 22, 2018EXHIBITPATENT OWNER

Aleve FDA approval 1994

May 22, 2018EXHIBITPATENT OWNER

Naproxen Sodium Softgel FDA approval 2006

May 22, 2018EXHIBITPATENT OWNER

Tabibi 2000

May 22, 2018EXHIBITPATENT OWNER

Seager and Slabaugh 1979

May 22, 2018EXHIBITPATENT OWNER

Gennadios 2002

May 22, 2018EXHIBITPATENT OWNER

Assignment from Banner to Patheon

May 22, 2018EXHIBITPATENT OWNER

Merck Index

May 22, 2018EXHIBITPATENT OWNER

Chang 1998

May 22, 2018EXHIBITPATENT OWNER

Patent Owner's Preliminary Response

May 22, 2018PAPERPATENT OWNER

Updated Mandatory Notices

Apr 20, 2018PAPERPATENT OWNER

Notice of Accord Filing Date

Feb 22, 2018PAPERBOARD

Patent Owner Power of Attorney

Feb 14, 2018PAPERPATENT OWNER

Patent Owner Mandatory Notice

Feb 14, 2018PAPERPATENT OWNER

Petitioner's Power of Attorney

Jan 14, 2018PAPERPETITIONER

Declaration of Peter Draper

Jan 14, 2018EXHIBITPETITIONER

Curriculum Vitae of Peter Draper

Jan 14, 2018EXHIBITPETITIONER

U.S. Patent No. 9,693,978

Jan 14, 2018EXHIBITPETITIONER

Prosecution History of U.S. 9,693,978 (60/659,679)

Jan 14, 2018EXHIBITPETITIONER

Prosecution History of U.S. Patent No. 9,693,978 (App. No. 14/977,808)

Jan 14, 2018EXHIBITPETITIONER

U.S. Patent No. 6,383,471 (¿¿¿Chen¿¿¿)

Jan 14, 2018EXHIBITPETITIONER

U.S. Publication No. 20040224020 (¿¿¿Schoenhard¿¿¿)

Jan 14, 2018EXHIBITPETITIONER

U.S. Patent No. 5,141,961 (¿¿¿Coapman¿¿¿)

Jan 14, 2018EXHIBITPETITIONER

U.S. Patent No. 5,641,512 (¿¿¿Cimileuca¿¿¿)

Jan 14, 2018EXHIBITPETITIONER

U.S. Patent No. 5,360,615 (¿¿¿Yu¿¿¿)

Jan 14, 2018EXHIBITPETITIONER

U.S. Patent No. 6,383,515 (¿¿¿Sawyer¿¿¿)

Jan 14, 2018EXHIBITPETITIONER

U.S. Publication No. 20060099246 (¿¿¿Tanner¿¿¿)

Jan 14, 2018EXHIBITPETITIONER

Wikipedia, Conjugate acid (July 8, 2016)

Jan 14, 2018EXHIBITPETITIONER

U.S. Publication No. 20050158377 (¿¿¿Popp¿¿¿)

Jan 14, 2018EXHIBITPETITIONER

U.S. Patent No. 6,066,339 (¿¿¿Stark¿¿¿)

Jan 14, 2018EXHIBITPETITIONER

U.S. Patent No. 6,251,426 (¿¿¿Gullapalli¿¿¿)

Jan 14, 2018EXHIBITPETITIONER

Banner Pharmacaps, Inc. Citizen Petition to the Food and Drug Administration

Jan 14, 2018EXHIBITPETITIONER

Wikipedia, Robert Pauli Scherer, https://en.wikipedia.org/wiki/Robert_Pauli_Scherer (January 8, 2018)

Jan 14, 2018EXHIBITPETITIONER

Prosecution History of U.S. 9,693,978 (11/367,238)

Jan 14, 2018EXHIBITPETITIONER

Prosecution History of EP 1863458 (Counterpart of U.S. Patent No. 9,693,978) (Part A)

Jan 14, 2018EXHIBITPETITIONER

Prosecution History of EP 1863458 (Counterpart of U.S. Patent No. 9,693,978) (Part B)

Jan 14, 2018EXHIBITPETITIONER

Prosecution History of U.S. Patent No. 9,693,979 (App. No. 15/159,972)

Jan 14, 2018EXHIBITPETITIONER

U.S. Publication No. 20040157928 (¿¿¿Kim¿¿¿)

Jan 14, 2018EXHIBITPETITIONER

R.M.C. Dawson et al., Data for Biochemical Research (Oxford: Clarendon Press 1959)

Jan 14, 2018EXHIBITPETITIONER

Letter from Sharon Hertz, Department Of Health & Human Services, to Roche Palo Alto LLC regarding NDA 18-965 (November 10, 2004)

Jan 14, 2018EXHIBITPETITIONER

U.S. Patent No. 3,035,973 (¿¿¿Klotz¿¿¿)

Jan 14, 2018EXHIBITPETITIONER

Banner Pharmacaps Inc. NDA 21-920, Naproxen Sodium Capsules

Jan 14, 2018EXHIBITPETITIONER

Petition for Inter Partes Review of U.S. Patent No. 9,693,978

Jan 14, 2018PAPERPETITIONER

Jarkko Rautio et al., ¿¿¿In Vitro Evaluation of Acyloxyalkyl Esters as Dermal Prodrugs of Ketoprofen and Naproxen,¿¿¿ Journal of Pharmaceutical Sciences, Vol. 87, No. 12, 1622-1628 (December 1998)

Jan 14, 2018EXHIBITPETITIONER

H. Sevelius et al., ¿¿¿Bioavailability of Naproxen Sodium and Its Relationship to Clinical Analgesic Effects,¿¿¿ 10 Br. J. Clin. Pharmac. 259-263 (1980)

Jan 14, 2018EXHIBITPETITIONER

Robert Thornton Morrison & Robert Neilson Boyd, Organic Chemistry (4th ed., Allyn and Bacon, Inc. 1983)

Jan 14, 2018EXHIBITPETITIONER